Systemic Inflammatory Response Syndrome (SIRS) Completed Phase 2 Trials for Tocilizumab (DB06273)
Also known as: Septic Syndrome / Systemic Inflammatory Response Syndrome / SIRS / Sepsis syndrome / Systemic inflammatory response syndrome (disorder) / Sepsis syndrome (disorder) / Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction / SIRS - System inflammatory response syndrome / Abacteraemic sepsis / Culture-negative sepsis / Abacteremic sepsis
| Indication | Status | Phase |
|---|---|---|
| DBCOND0053489 (Systemic Inflammatory Response Syndrome (SIRS)) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03863015 | IL-6 Inhibition for Modulating Inflammation After Cardiac Arrest | Treatment |